Leukemia Supplements- Table of Contents alert Volume 1 Issue S2

Proceedings from Leukemia 2012 19–20 April 2012, Milan Chairmen: ANGELO M CARELLA, Director, Division of Hematology, IRCCS AOU San Martino-IST, Genova ENRICA MORRA, Director, Division of Hematology, Ca'Granda-Niguarda Hospital, Milano TABLE OF CONTENTS Volume 1, Issue S2 (August 2012) In this issue Session I: Acute Lymphoblastic Leukemia (ALL) Session II: Acute Myeloid Leukemia (AML) Session III: News And Perspectives in Infectious Complications of Leukemias Session IV: Chronic Lymphocytic Leukemia (CLL) Session V: Chronic Myeloid Leukemia (CML) Advertisement BD Reagents for Blood Cell Disorders Part of the building blocks to support patient care for blood cell disorders, BD Biosciences reagents provide a full spectrum of color choices, allowing you to analyze multiple parameters simultaneously and access a whole new world of information and insight. Welcome to a more colorful world SM. bdbiosciences.com/go/color Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Take part in our reader survey for a chance to win a MacBook Air As a reader of NPG's clinical, academic and society-owned journals, we invite you to take part in a survey on your use of our journals and their associated websites. Take the survey and be entered into a prize draw for a MacBook Air* *Terms & conditions apply   Session I: Acute Lymphoblastic Leukemia (ALL) Top Change in prognostic factors D Hoelzer and N Gökbuget Leukemia Supp 2012 1: S1-S2; 10.1038/leusup.2012.4 Abstract | Full Text Minimal residual disease D Campana Leukemia Supp 2012 1: S3-S4; 10.1038/leusup.2012.5 Abstract | Full Text Modern therapy of young and adult Ph-ALL R Bassan, T Intermesoli, O Spinelli, E Oldani and A Rambaldi Leukemia Supp 2012 1: S5-S6; 10.1038/leusup.2012.6 Abstract | Full Text Management of Philadelphia chromosome-positive acute lymphoblastic leukemia O G Ottmann Leukemia Supp 2012 1: S7-S9; 10.1038/leusup.2012.7 Abstract | Full Text Advances in unrelated cord blood transplants in malignancies E Gluckman Leukemia Supp 2012 1: S10-S11; 10.1038/leusup.2012.8 Abstract | Full Text Session II: Acute Myeloid Leukemia (AML) Top Prognostic markers in AML: focus on CBFL R Cairoli, A Beghini, M Turrini, G Bertani and E Morra Leukemia Supp 2012 1: S12-S13; 10.1038/leusup.2012.9 Abstract | Full Text Optimal induction and post-remission therapy for acute myeloid leukemia A K Burnett Leukemia Supp 2012 1: S14-S15; 10.1038/leusup.2012.10 Abstract | Full Text Treating older patients with AML S Amadori Leukemia Supp 2012 1: S16-S17; 10.1038/leusup.2012.11 Abstract | Full Text Novel strategies in treatment of acute promyelocytic leukemia F Lo-Coco and L Cicconi Leukemia Supp 2012 1: S18-S19; 10.1038/leusup.2012.12 Abstract | Full Text Session III: News And Perspectives in Infectious Complications of Leukemias Top Antibiotic therapy in hematological neutropenic patients: what is the news? F Pea Leukemia Supp 2012 1: S20-S21; 10.1038/leusup.2012.13 Abstract | Full Text Fungal infections: diagnostic problems and choice of therapy B E de Pauw Leukemia Supp 2012 1: S22-S23; 10.1038/leusup.2012.14 Abstract | Full Text Viral infections in patients with hematological malignancies A Busca Leukemia Supp 2012 1: S24-S25; 10.1038/leusup.2012.15 Abstract | Full Text Session IV: Chronic Lymphocytic Leukemia (CLL) Top The genome of chemorefractory chronic lymphocytic leukemia reveals frequent mutations of NOTCH1 and SF3B1 D Rossi, S Rasi, V Spina, A Bruscaggin, S Monti, S Cresta, R Famà, C Deambrogi, M Greco, M Fangazio, C Ciardullo, D Piranda, G M Casaluci, M Messina, I D Giudice, S Chiaretti, M Marinelli, A Guarini, R Foà and G Gaidano Leukemia Supp 2012 1: S26-S28; 10.1038/leusup.2012.16 Abstract | Full Text Prognostic factors in CLL M Ferrarini, G Cutrona, A Neri and F Morabito Leukemia Supp 2012 1: S29-S30; 10.1038/leusup.2012.17 Abstract | Full Text Chronic lymphocytic leukemia: treatment of relapse M Montillo Leukemia Supp 2012 1: S31-S32; 10.1038/leusup.2012.18 Abstract | Full Text Challenges for the next decade: allogeneic stem cell transplantation in chronic lymphocytic leukemia P Corradini and L Farina Leukemia Supp 2012 1: S33-S34; 10.1038/leusup.2012.19 Abstract | Full Text Molecular basis of myelodysplastic syndromes M Cazzola Leukemia Supp 2012 1: S35-S36; 10.1038/leusup.2012.20 Abstract | Full Text Session V: Chronic Myeloid Leukemia (CML) Top Initial treatment for patients with chronic myeloid leukemia M Baccarani Leukemia Supp 2012 1: S37-S39; 10.1038/leusup.2012.21 Abstract | Full Text Second-generation TKIs: which and when? G Saglio Leukemia Supp 2012 1: S40-S42; 10.1038/leusup.2012.22 Abstract | Full Text Biology of CML stem cells: the basis for clinical heterogeneity? J M Goldman, M Gordon, A Bazeos and D Marin Leukemia Supp 2012 1: S43-S45; 10.1038/leusup.2012.23 Abstract | Full Text Stem cell persistence in chronic myeloid leukemia M Deininger Leukemia Supp 2012 1: S46-S48; 10.1038/leusup.2012.24 Abstract | Full Text Inhibition of autophagy with clarithromycin: a new strategy to enhance sensitivity of CML stem cells to tyrosine kinase inhibitors A M Carella, G Beltrami, G Catania, G Pica, C Ghiggi, A Garuti and A Carella Leukemia Supp 2012 1: S49-S50; 10.1038/leusup.2012.25 Abstract | Full Text Where are we going with CML research? D Perrotti Leukemia Supp 2012 1: S51-S53; 10.1038/leusup.2012.26 Abstract | Full Text Normal and leukemic stem cells P G Pelicci Leukemia Supp 2012 1: S54-S55; 10.1038/leusup.2012.27 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Leukemia Supplements. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.